MELINDA TELLIER: Open Payments
NPI 1861706913 · GENESEO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 5 companies in 2025. Trend: 2023 $215 · 2024 $263 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lilly USA, LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $18 |
Products named: Ozempic, CAPLYTA, MOUNJARO, BREZTRI, Wegovy, Dexcom G6 Transmitter, FARXIGA.
Industry payments across NY — which companies pay providers there.
